Bone Biologics Corporation (BBLG)
Develops protein-based implants that help bones regrow during spine surgery.
$0.97-0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-64.5%
The outlook
BBLG is trading near its 52-week low at $0.97, well below both its 50- and 200-day moving averages. Analyst coverage shows a sharp disconnect—the average price target implies substantial upside, though the stock's bearish score (19/100) and positioning at the bottom of its yearly range reflect current weakness.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +1158% vs current price
Market cap
$1.7M
52-wk high
$4.13
52-wk low
$0.96
50-day avg
$1.29
200-day avg
$1.51
Trailing P/E
—